AVX-001

N/A

Report date: 2024/11/25 20:00:28
NME

Base Information

Drug NameAVX-001
Drug Alias NameAKH-217AVX-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsCytosolic phospholipase A2 inhibitors
TargetsCytosolic phospholipase A2
Therapy Area/IndicationsKeratosis, ActinicCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvexxin Oncology AS
China Registration ClassN/A

Develop Information

Active CompaniesCoegin Pharma AB
Inactive CompaniesN/A
Active IndicationsCarcinoma, Basal Cell
Inactive IndicationsKeratosis, Actinic

Other Information

ATC CodeN/A
Related LinksN/A